Novel N-CF3 imide aza-cyclic compound and preparation method thereof

The N-CF3 synthon, formed by the novel trifluoromethylating agent PhICF3Cl and acetonitrile, reacts with hydroxyl-substituted six-membered nitrogen heterocyclic compounds to directly synthesize N-CF3-type imide nitrogen heterocyclic compounds. This solves the synthesis problem of existing technologies and promotes the application of such compounds in the fields of biomedicine and materials.

CN119059964AInactive Publication Date: 2024-12-03QUZHOU RES INST OF ZHEJIANG UNIV
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
CN202411184793.7
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-27
Publication Date
2024-12-03
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

Existing technologies make it difficult to efficiently synthesize N-CF3-type imide nitrogen heterocyclic compounds, which limits the application of trifluoromethyl groups in nitrogen-containing compounds.

Method used

N-CF3-type imide nitrogen heterocyclic compounds were directly synthesized by reacting the N-CF3 synthon, formed in-situ with acetonitrile using the novel trifluoromethylating agent PhICF3Cl, with hydroxyl-substituted six-membered nitrogen heterocyclic compounds.

Benefits of technology

The direct synthesis of N-CF3-type imide nitrogen heterocyclic compounds has been achieved, providing a new method for introducing trifluoromethyl groups into nitrogen-containing compounds and promoting the application of such compounds in the fields of biomedicine and materials.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119059964A_ABST
    Figure CN119059964A_ABST
Patent Text Reader

Abstract

The invention discloses a novel N-CF3 type imide aza-cyclic compound and a preparation method of the novel N-CF3 type imide aza-cyclic compound. According to the invention, the synthesis of the N-CF3 imide aza-cyclic compound is directly realized for the first time. According to the invention, an N-CF3 synthon formed by a novel trifluoromethylation reagent PhICF3Cl and acetonitrile on site is used as an electrophilic reagent and reacts with a hydroxyl-substituted six-membered nitrogen heterocyclic compound, so that the synthesis of the N-CF3 imide nitrogen heterocyclic compound is directly realized. The invention provides a new thought and method for introducing a trifluoromethyl group into a nitrogen-containing compound, and can greatly promote the application of the compound in the fields of biological medicines and materials.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of organic synthesis and preparation, and specifically relates to a novel N-CF3 type imide nitrogen heterocyclic compound and a preparation method thereof. Background Art

[0002] Fluorine atoms are introduced into organic molecules. Due to the characteristics of fluorine atoms themselves and the existence of fluorine effect, fluorine-containing compounds exhibit many unique properties. Especially in the field of biomedicine, the study of the synthesis of fluorine-containing compounds is one of the research hotspots of contemporary organic chemistry and an important development direction of modern drug synthesis. Among them, the introduction of trifluoromethyl groups is the most important component in the field of fluorine chemistry. At present, the method of using trifluoromethyl reagents to directly introduce trifluoromethyl functional groups into organic compounds is the most common method because it does not involve the breakage and generation of CF. [1] .

[0003] The N-CF3 group is a very valuable group in drug design. The synthesis of complex drugs and physiologically active molecules containing NCF3 structures directly through N-CF3 synthons is a practical method that has attracted much attention in recent years. However, due to the limitations of synthetic methods and synthetic reagents, there are few reports of ready-made multifunctional NCF3 synthons. In recent years, a new type of exo-coordinated electrophilic trifluoromethylation reagent, PhICF3Cl, has been discovered and widely used to introduce trifluoromethyl functional groups. [2] In 2022, Wang Mang's team discovered that the presence of N-CF3 derivatives could be detected on-site by mixing PhICF3Cl with acetonitrile. Based on this, they designed a trifluoromethylation [3+2] cyclization strategy and successfully achieved the synthesis of a series of N-CF3 azole compounds. [3] ,like Figure 1 shown.

[0004] Nitrogen-containing heterocyclic compounds are inseparable from human life. They usually have unique biological activity, low toxicity and high systemicity, and are often used as structural units of medicines and pesticides. According to statistics, more than half of the drug molecules approved by the US Food and Drug Administration (FDA) contain at least one nitrogen heterocyclic ring. At the same time, nitrogen-containing heterocyclic compounds are easy to modify their structure and can easily introduce various functional groups. They are also used in fields such as organic metal catalytic materials and dye-sensitized solar cells. [4] Introducing trifluoromethyl functional groups into nitrogen-containing heterocyclic compounds can combine the excellent properties of nitrogen heterocyclic compounds and fluorine-containing compounds, and developing nitrogen heterocyclic trifluoromethyl compounds with good physiological activity, high efficiency and strong practicality is expected to become one of the research hotspots in organic synthetic chemistry.

[0005] References [1] (1) Furuya T, Kamlet A S, Ritter T. Catalysis for Fluorinationand Trifluoromethylation[J]. Nature, 2011, 473, 470-477; (2) Liu X, Xu C,Wang M, et al. Trifluoromethyltrimethylsilane: NucleophilicTrifluoromethylation and Beyond[J]. Chemical Reviews, 2015, 115(2): 683-730;(3) Chu L, Qing F-L. Oxidative Trifluoromethylation andTrifluoromethylthiolation Reactions Using (Trifluoromethyl)trimethylsilane asa Nucleophilic CF3 Source[J]. Accounts of Chemical Research, 2014, 47(5):1513-1522; (4) Nie J, Guo H -C, Cahard D, et al. Asymmetric Construction ofStereogenic Carbon Centers Featuring a Trifluoromethyl Group from ProchiralTrifluoromethylated Substrates[J]. Chemical Reviews, 2011, 111(2): 455-529. [2] (1) Xu C, Liu J, Ming W, et al. In Situ Generation of PhI + CF3 andTransition Metal Free Oxidative sp 2CH Trifluoromethylation[J]. Chemistry AEuropean Journal, 2013, 19(28): 9104-9109; (2) Xu C, Song X, Guo J, et al.Synthesis of Chloro(phenyl)trifluoromethyliodane and Catalyst-FreeElectrophilic Trifluoromethylations[J]. Organic Letters, 2018, 20(13): 3933-3937. [3] Zhang R. Z, Zhang R. [4] (1) Li R, Li B, Zhang H, et al. A Ring Expansion Strategy towards Diverse Azaheterocycles[J]. Nature Chemistry 2021,13, 1006–1016; (2) VitakuE, Smith D. T, Njardarson J. T, Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among US FDAApproved Pharmaceuticals[J]. J. Med. Chem. 2014, 57(24): 10257–10274. Summary of the invention

[0006] The purpose of the present invention is to directly realize the synthesis of N-CF3-type imide nitrogen heterocyclic compounds for the first time by using a novel trifluoromethylation reagent PhICF3Cl and acetonitrile to form an N-CF3 synthon in situ as an electrophilic reagent to react with a hydroxyl-substituted six-membered nitrogen heterocyclic compound.

[0007] In order to achieve the above object, the present invention adopts the following technical solution: A novel N-CF3-type imide nitrogen heterocyclic compound, wherein the structure of the nitrogen heterocyclic compound contains an imide-like functional group of an N-CF3 structure; and the structure of the nitrogen heterocyclic compound is as follows: ; Here, R represents a six-membered nitrogen heterocyclic compound.

[0008] A novel method for preparing N-CF3-type imide nitrogen heterocyclic compounds is specifically implemented as follows: The nitrogen heterocyclic compound containing a hydroxyl structure and PhIClCF3 are dissolved in a solvent containing acetonitrile, stirred and mixed, and the reaction temperature and reaction time are controlled. After the reaction is completed, the solvent is removed and separated to obtain an N-CF3 type imide nitrogen heterocyclic compound.

[0009] Preferably, the hydroxy-substituted six-membered nitrogen heterocyclic compound includes one or more of hydroxypyridine, hydroxyquinoline, hydroxyisoquinoline, hydroxypyridazine and hydroxypyrimidine.

[0010] Preferably, the reaction solvent used refers to acetonitrile or a mixed solvent containing acetonitrile, in which the proportion of acetonitrile is 0-100%, and the volume ratio of reactants to solvent is 1:10-100.

[0011] Preferably, the reaction temperature is controlled at 0-80 °C and the reaction time is 0.5-5 h.

[0012] Preferably, the reaction is completed in one reaction system, which is a one-pot reaction.

[0013] The beneficial effects of the present invention are as follows: The present invention directly realizes the synthesis of N-CF3-type imide nitrogen heterocyclic compounds for the first time, and provides a new idea and method for introducing trifluoromethyl groups into nitrogen-containing compounds, which will greatly promote the application of such compounds in the fields of biomedicine and materials. BRIEF DESCRIPTION OF THE DRAWINGS

[0014] Figure 1 Synthesis of N-CF3 azole compounds based on N-CF3 synthon; Figure 2 An example of the synthesis of N-CF3-based imide nitrogen heterocyclic compounds based on N-CF3 synthons; Figure 3 Schematic diagram of the nuclear magnetic resonance of 2-bromo-4-N-(trifluoromethyl)ethyleneimine pyridine ester of the present invention ( 1 H-NMR); Figure 4Schematic diagram of the nuclear magnetic resonance of 2-bromo-4-N-(trifluoromethyl)ethyleneimine pyridine ester of the present invention ( 19 F-NMR); DETAILED DESCRIPTION

[0015] The following description is only a preferred embodiment of the present invention and does not limit the present invention. For those skilled in the art, various changes and variations are possible. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included in the protection scope of the present invention.

[0016] like Figure 2 As shown, the present invention uses the N-CF3 synthon formed on-site by the novel trifluoromethylation reagent PhICF3Cl and acetonitrile as an electrophilic reagent to react with a hydroxyl-substituted six-membered nitrogen heterocyclic compound, thereby directly realizing the synthesis of N-CF3-type imide nitrogen heterocyclic compounds for the first time, providing a new idea and method for introducing trifluoromethyl groups into nitrogen-containing compounds, which will greatly promote the application of such compounds in the fields of biomedicine and materials.

[0017] Example 1 In a dry reaction vessel, 2-bromo-4-hydroxypyridine (0.174 g, 1.0 mmol), PhICF3Cl (0.463 g, 1.5 mmol), and 10 mL of acetonitrile were added in sequence and stirred at room temperature for 5 h. The solvent was removed by vortexing, and after separation, 0.246 g of the corresponding target product (2-bromo-4-N-(trifluoromethyl)ethyleneimine pyridine ester) was obtained with a yield of 87%.

[0018] Example 2 In a dry reaction vessel, 4-hydroxypyridine (0.095 g, 1.0 mmol), PhICF3Cl (0.463 g, 1.5 mmol), and 10 mL of acetonitrile were added in sequence and stirred at 30 °C for 3 h. The solvent was removed by vortexing, and after separation, 0.153 g of the corresponding target product (4-N-(trifluoromethyl)ethyleneimine pyridine ester) was obtained with a yield of 75%.

[0019] Example 3 In a dry reaction vessel, 2-bromo-4-hydroxypyridine (0.174 g, 1.0 mmol), PhICF3Cl (0.309 g, 1.0 mmol), and 10 mL of a mixed solution (acetonitrile: dichloromethane = 1:2) were added in sequence and stirred at 45 °C for 1.5 h. The solvent was removed by vortexing, and after separation, 0.150 g of the corresponding target product (2-bromo-4-N-(trifluoromethyl)ethyleneimine pyridine ester) was obtained with a yield of 53%.

[0020] Example 4 In a dry reaction vessel, 2-bromo-4-hydroxypyridine (0.174 g, 1.0 mmol), PhICF3Cl (0.309 g, 1.0 mmol), and 10 mL of a mixed solution (acetonitrile:DMF = 3:1) were added in sequence and stirred at 80 °C for 0.5 h. After extraction, filtration, concentration, and separation, 0.136 g of the corresponding target product (2-bromo-4-N-(trifluoromethyl)ethyleneimine pyridine ester) was obtained with a yield of 48%.

[0021] Example 5 In a dry reaction vessel, 5-bromo-4-hydroxyquinoline (0.224 g, 1.0 mmol), PhICF3Cl (0.400 g, 1.3 mmol), and 15 mL of acetonitrile were added in sequence and stirred at 30 °C for 5 h. After concentration and separation, 0.150 g of the corresponding target product (5-bromo-4-N-(trifluoromethyl)ethyliminoquinoline ester) was obtained with a yield of 45%.

[0022] Example 6 In a dry reaction vessel, 2-Cl-5-hydroxypyrimidine (0.131 g, 1.0 mmol), PhICF3Cl (0.371 g, 1.2 mmol), and acetonitrile 20 mL were added in sequence and stirred at room temperature for 4.5 h. After concentration and separation, 0.144 g of the corresponding target product (2-chloro-5-N-(trifluoromethyl)ethylimidazole pyrimidine ester) was obtained with a yield of 60%.

[0023] Example 7 In a dry reaction vessel, 4-hydroxypyridazine (0.097 g, 1.0 mmol), PhICF3Cl (0.371 g, 1.2 mmol), and acetonitrile 20 mL were added in sequence and stirred at room temperature for 4.5 h. After concentration and separation, 0.061 g of the corresponding target product (4-N-(trifluoromethyl)ethyliminopyridazine ester) was obtained with a yield of 30%.

[0024] Example 8 In a dry reaction vessel, 5-bromo-4-hydroxyisoquinoline (0.224 g, 1.0 mmol), PhICF3Cl (0.400 g, 1.3 mmol), and 15 mL of acetonitrile were added in sequence and stirred at room temperature for 5 h. After concentration and separation, 0.143 g of the corresponding target product (5-bromo-4-N-(trifluoromethyl)ethyliminoisoquinoline ester) was obtained with a yield of 43%.

[0025] Compound verification like Figure 3 and 4The NMR of the compound 2-bromo-4-N-(trifluoromethyl)ethylimine pyridinium ester in Examples 1, 3 and 4 is shown below. 1 H-NMR (400 MHz, CDCl3): δ = 8.34 (d, J = 4.32 Hz,1H), 7.25 (d, J = 1.48 Hz, 1H), 7.03 (dd, J = 4.40 Hz, 1.56 Hz, 1H), 2.37 (s,3H). 19 F-NMR (376 MHz, CDCl3): δ = -53.78 (s, 3F).

Claims

1. A novel N-CF3 type imide nitrogen heterocyclic compound, characterized in that: The nitrogen heterocyclic compound structure contains an imide-like functional group of N-CF3 structure; According to a novel N-CF3 type imide nitrogen heterocyclic compound according to claim 1, it is characterized in that the nitrogen heterocyclic compound has the following structure: ; Here, R represents a six-membered nitrogen heterocyclic compound.

2. A novel N-CF3 type imide nitrogen heterocyclic compound according to claim 1, characterized in that: The nitrogen heterocyclic compound is a hydroxy-substituted six-membered nitrogen heterocyclic compound, including one or more of hydroxypyridine, hydroxyquinoline, hydroxyisoquinoline, hydroxypyridazine and hydroxypyrimidine.

3. The method for preparing a novel N-CF3 type imide nitrogen heterocyclic compound according to claim 1, characterized in that: The nitrogen heterocyclic compound containing a hydroxyl structure and a trifluoromethylation agent are dissolved in a solvent containing acetonitrile, stirred and mixed, and the reaction temperature and reaction time are controlled. After the reaction is completed, the solvent is removed and separated to obtain an N-CF3 type imide nitrogen heterocyclic compound.

4. The method for preparing a novel N-CF3 type imide nitrogen heterocyclic compound according to claim 4, characterized in that: The trifluoromethylation reagent used is PhICF3Cl.

5. The method for preparing a novel N-CF3 type imide nitrogen heterocyclic compound according to claim 4, characterized in that: Direct synthesis using in situ generated N-CF3 as a synthon.

6. The method for preparing a novel N-CF3 type imide nitrogen heterocyclic compound according to claim 4, characterized in that: The volume ratio of the reactants to the reaction solvent is 1:10~100.

7. The method for preparing a novel N-CF3 type imide nitrogen heterocyclic compound according to claim 4, characterized in that: The reaction solvent used refers to acetonitrile or a mixed solvent containing acetonitrile, in which the proportion of acetonitrile is 1-100%.

8. The method for preparing a novel N-CF3 type imide nitrogen heterocyclic compound according to claim 4, characterized in that: The reaction temperature is controlled at 0-80 °C; the reaction time is controlled at 0.5-5 h; the reaction vessel is one or more of a reaction kettle, a flask, a sealed tube, and a liquid storage bottle.

9. The method for preparing a novel N-CF3 type imide nitrogen heterocyclic compound according to claim 4, characterized in that: The reaction is completed in a reaction system and is a one-pot reaction.

Citation Information

Patent Citations

  • Preparation method and application of N-(N-trifluoromethyl imino acyl) pyridinium salt

    CN113979932A